ES546728A0 - Metodo de preparar composiciones farmaceuticas con perfil de desprendimiento controlado bifasico de sustancia activa desde un nucleo de farmaco y desde los poros de un revestimiento de membrana circundante del nucleo. - Google Patents

Metodo de preparar composiciones farmaceuticas con perfil de desprendimiento controlado bifasico de sustancia activa desde un nucleo de farmaco y desde los poros de un revestimiento de membrana circundante del nucleo.

Info

Publication number
ES546728A0
ES546728A0 ES546728A ES546728A ES546728A0 ES 546728 A0 ES546728 A0 ES 546728A0 ES 546728 A ES546728 A ES 546728A ES 546728 A ES546728 A ES 546728A ES 546728 A0 ES546728 A0 ES 546728A0
Authority
ES
Spain
Prior art keywords
nucleus
active substance
biphassic
pharmacy
pores
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES546728A
Other languages
English (en)
Other versions
ES8702138A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leo AB
Original Assignee
Leo AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo AB filed Critical Leo AB
Publication of ES546728A0 publication Critical patent/ES546728A0/es
Publication of ES8702138A1 publication Critical patent/ES8702138A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Control Of Temperature (AREA)
  • Slot Machines And Peripheral Devices (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
ES546728A 1984-09-06 1985-09-05 Metodo de preparar composiciones farmaceuticas con perfil de desprendimiento controlado bifasico de sustancia activa desde un nucleo de farmaco y desde los poros de un revestimiento de membrana circundante del nucleo. Expired ES8702138A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8404467A SE8404467D0 (sv) 1984-09-06 1984-09-06 Controlled-release medical preparations

Publications (2)

Publication Number Publication Date
ES546728A0 true ES546728A0 (es) 1986-12-16
ES8702138A1 ES8702138A1 (es) 1986-12-16

Family

ID=20356934

Family Applications (1)

Application Number Title Priority Date Filing Date
ES546728A Expired ES8702138A1 (es) 1984-09-06 1985-09-05 Metodo de preparar composiciones farmaceuticas con perfil de desprendimiento controlado bifasico de sustancia activa desde un nucleo de farmaco y desde los poros de un revestimiento de membrana circundante del nucleo.

Country Status (21)

Country Link
US (1) US4824678A (es)
EP (1) EP0173928B1 (es)
JP (1) JP2527713B2 (es)
KR (1) KR930003114B1 (es)
AT (1) ATE53490T1 (es)
AU (1) AU576891B2 (es)
CA (1) CA1252723A (es)
DE (1) DE3578123D1 (es)
DK (1) DK164256C (es)
ES (1) ES8702138A1 (es)
FI (1) FI87042C (es)
GR (1) GR852158B (es)
HU (1) HU194495B (es)
IE (1) IE58263B1 (es)
IL (2) IL76257A (es)
NO (1) NO169996C (es)
NZ (1) NZ213245A (es)
PH (1) PH22119A (es)
PT (1) PT81092B (es)
SE (1) SE8404467D0 (es)
ZA (1) ZA856547B (es)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4917899A (en) * 1983-12-22 1990-04-17 Elan Corporation Plc Controlled absorption diltiazem formulation
IE56999B1 (en) * 1983-12-22 1992-03-11 Elan Corp Plc Pharmaceutical formulation
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
IE59287B1 (en) * 1984-02-10 1994-02-09 Benzon Pharma As Diffusion coated multiple-units dosage form
US5624683A (en) * 1986-08-06 1997-04-29 Eisai Co., Ltd. Sustained-release multi-granule tablet
DE3720757A1 (de) * 1987-06-24 1989-01-05 Bayer Ag Dhp-manteltablette
US5073381A (en) * 1988-08-15 1991-12-17 University Of Akron Amphiphilic networks
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
US5178868A (en) * 1988-10-26 1993-01-12 Kabi Pharmacia Aktiebolaq Dosage form
SE8803822D0 (sv) * 1988-10-26 1988-10-26 Novel dosage form
US5240601A (en) * 1988-11-09 1993-08-31 Chembiomed, Ltd. Affinity supports for hemoperfusion
US5149425A (en) * 1988-11-09 1992-09-22 Chembiomed, Ltd. Affinity supports for hemoperfusion
DE9190107U1 (de) * 1990-08-07 1993-12-16 Pfizer Inc., New York, N.Y. Abgabe-Vorrichtung mit durch Grenzflächen-Polymerisation erhaltenen Membranen
US5288505A (en) * 1991-06-26 1994-02-22 Galephar P.R., Inc., Ltd. Extended release form of diltiazem
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
ZA933725B (en) * 1992-05-28 1993-12-15 Elan Corp Plc Tablet formulation
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
ES2113094T3 (es) * 1993-03-09 1998-04-16 Epic Therapeutics Inc Las microparticulas macromoleculares y metodos de obtencion.
US5547948A (en) * 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
EP1005863A1 (en) 1998-12-04 2000-06-07 Synthelabo Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof
EP1064937A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
GB9923045D0 (en) * 1999-09-29 1999-12-01 Novartis Ag New oral formulations
US20060153914A1 (en) * 1999-12-10 2006-07-13 Biovail Laboratories International S.R.L. Chronotherapeutic diltiazem formulations and the administration thereof
US7108866B1 (en) 1999-12-10 2006-09-19 Biovall Laboratories International Srl Chronotherapeutic diltiazem formulations and the administration thereof
AU2276801A (en) 1999-12-20 2001-07-03 Schering Corporation Extended release oral dosage composition
AU2277101A (en) 1999-12-20 2001-07-03 Schering Corporation Stable extended release oral dosage composition
SE0100200D0 (sv) 2001-01-24 2001-01-24 Astrazeneca Ab New film coating
US6960357B2 (en) 2001-05-25 2005-11-01 Mistral Pharma Inc. Chemical delivery device
BR0211317A (pt) * 2001-07-04 2004-12-14 Sun Pharmaceutical Ind Ltd Sistema para a liberação controlada de uma droga por meio de retenção gástrica
US6602911B2 (en) * 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
DK1355633T3 (da) 2001-12-19 2005-04-04 Astrazeneca Ab Ny filmcoating, der indeholder en ethylacrylat/methylmethacrylat-copolymer og polyvinylacetat
PT1485078E (pt) * 2002-03-15 2013-01-14 Cypress Bioscience Inc Milnacipran para o tratamento do síndrome do intestino irritável
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US20040132826A1 (en) * 2002-10-25 2004-07-08 Collegium Pharmaceutical, Inc. Modified release compositions of milnacipran
GB0227948D0 (en) * 2002-11-29 2003-01-08 Cipla Ltd Pharmaceutical combinations comprising b-2 adrenoreceptor agonists and xanthines
AU2004207578B2 (en) * 2003-01-28 2007-06-28 Collegium Pharmaceutical, Inc. Multiparticulate compositions of milnacipran for oral administration
US7862835B2 (en) * 2004-10-27 2011-01-04 Boston Scientific Scimed, Inc. Method of manufacturing a medical device having a porous coating thereon
US7994220B2 (en) * 2005-09-28 2011-08-09 Cypress Bioscience, Inc. Milnacipran for the long-term treatment of fibromyalgia syndrome
WO2007065559A1 (en) * 2005-11-18 2007-06-14 Synthon B.V. Zolpidem tablets
US7427414B2 (en) * 2006-01-18 2008-09-23 Astron Research Limited Modified release oral dosage form using co-polymer of polyvinyl acetate
CN102440992A (zh) * 2011-12-19 2012-05-09 岳阳新华达制药有限公司 含有盐酸班布特罗和多索茶碱复方制剂及其制备方法
WO2017026950A1 (en) 2015-08-07 2017-02-16 Santa Farma Ilac San. A. S. Controlled release propiverine formulations
WO2020101586A1 (en) 2018-11-16 2020-05-22 Santa Farma İlaç Sanayi̇ A.Ş. Controlled release propiverine formulations
EP4251154A4 (en) 2020-11-27 2024-07-31 Santa Farma Ilac Sanayii A.S. SUSTAINED-RELEASE FORMULATION COMPOSITIONS COMPRISING PROPIVERINE

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE556141A (es) * 1956-03-27
US3538214A (en) * 1969-04-22 1970-11-03 Merck & Co Inc Controlled release medicinal tablets
EP0013131A3 (en) * 1978-12-27 1981-01-07 Mundipharma A.G. Pharmaceutical composition in solid dosage form, and process for its production
US4557925A (en) * 1982-07-08 1985-12-10 Ab Ferrosan Membrane-coated sustained-release tablets and method
JPH075457B2 (ja) * 1983-08-16 1995-01-25 ザ ウエルカム フアウンデ−シヨン リミテツド 調節された方法による有効成分の放出を可能にする医薬組成物
US4769027A (en) * 1984-08-15 1988-09-06 Burroughs Wellcome Co. Delivery system

Also Published As

Publication number Publication date
EP0173928A1 (en) 1986-03-12
AU4693585A (en) 1986-03-13
PH22119A (en) 1988-06-01
HU194495B (en) 1988-02-29
IE852070L (en) 1986-03-06
EP0173928B1 (en) 1990-06-13
FI87042B (fi) 1992-08-14
KR930003114B1 (ko) 1993-04-19
IL76256A0 (en) 1986-01-31
NO853407L (no) 1986-03-07
PT81092B (pt) 1988-01-22
ATE53490T1 (de) 1990-06-15
GR852158B (es) 1986-01-08
ZA856547B (en) 1986-04-30
IL76256A (en) 1990-06-10
AU576891B2 (en) 1988-09-08
IL76257A (en) 1989-05-15
FI853406A0 (fi) 1985-09-05
PT81092A (en) 1985-10-01
CA1252723A (en) 1989-04-18
KR860002271A (ko) 1986-04-24
NO169996C (no) 1992-09-02
ES8702138A1 (es) 1986-12-16
JPS61112013A (ja) 1986-05-30
US4824678A (en) 1989-04-25
DK164256B (da) 1992-06-01
DK400685D0 (da) 1985-09-02
JP2527713B2 (ja) 1996-08-28
NZ213245A (en) 1988-06-30
FI853406L (fi) 1986-03-07
DK164256C (da) 1992-10-19
HUT40333A (en) 1986-12-28
IE58263B1 (en) 1993-08-25
SE8404467D0 (sv) 1984-09-06
DK400685A (da) 1986-03-07
FI87042C (fi) 1992-11-25
NO169996B (no) 1992-05-25
DE3578123D1 (de) 1990-07-19

Similar Documents

Publication Publication Date Title
NO169996C (no) Fremgangsmaate ved fremstilling av et farmasoeytisk preparat med kontrollert utskillelse av virkestoff
AU646399B2 (en) Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
CA2033277A1 (en) Controlled release pharmaceutical preparation and method for producing the same
KR880004804A (ko) 분무건조 아세트 아미노펜
NO863997L (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
DE69024363D1 (de) Erodierbare makroporöse hydrogelpartikeln sowie deren herstellung
Kurumaddali et al. Preparation and evaluation of sustained release ibuprofen beads
EP0080117A3 (en) Enantiomers of trans-indeno(1,2-b)-1,4-oxazines, process for their preparation and pharmaceutical formulation containing them
DE2836355A1 (de) Neue mexiletin-retardform
DE2836387A1 (de) Retardform fuer einen blutdrucksenkenden und antanginoes wirkenden stoff
ATE3208T1 (de) Pyrido (2,3-d) pyrimidin-derivate, sie enthaltende pharmazeutische zusammensetzungen und verfahren zur herstellung der pyrido (2,3-d) pyrimidin-derivate.
ATE9157T1 (de) Pyrimidonderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen.
NL154507B (nl) Werkwijze voor de bereiding van een farmaceutisch preparaat dat een farmacologisch werkzaam derivaat van een tricyclisch gecondenseerd ringsysteem bevattend aminocarbonzuur bevat alsmede het verkregen gevormde farmaceutische preparaat, en werkwijze voor de bereiding van een voor opnemen in zo'n preparaat geschikt derivaat van een een tricyclisch gecondenseerd ringsysteem bevattend aminocarbonzuur.
ATE10933T1 (de) Neues peptid, verfahren zu dessen herstellung und pharmazeutische zusammensetzung.